Stay updated on Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedA site-wide notice says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition, and that both terms may appear across NIH content.SummaryDifference1.0%

- Check12 days agoChange DetectedThe site’s footer revision number changed from v3.7.2 to v3.8.0, while the clinical-trial record history remained unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedA site-wide NIH notice about its terminology transition appears at the top of the page.SummaryDifference0.9%

- Check26 days agoChange DetectedThe site footer now identifies the website as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check33 days agoChange DetectedThe site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history now includes a new system revision entry v3.7.0, replacing the previous v3.6.6 entry. This reflects a software version update in the study's history log.SummaryDifference0.1%

Stay in the know with updates to Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.